Covered recipient · General Payments record
ROBERT L GROAT
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,244.44
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $340.50 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $103.90 | 5 |
| ABBVIE INC. | $96.32 | 4 |
| Bausch & Lomb Americas Inc. | $45.53 | 2 |
| Tarsus Pharmaceuticals, Inc. | $29.57 | 1 |
| Amgen Inc. | $28.22 | 1 |
| Oyster Point Pharma, Inc. | $23.66 | 1 |
| Johnson & Johnson Vision Care, Inc. | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.21 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103841234 | CMS |
| ABBVIE INC. | $23.93 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103841236 | CMS |
| ABBVIE INC. | $21.91 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103841238 | CMS |
| ABBVIE INC. | $25.27 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103841240 | CMS |
| Alcon Vision LLC | $23.81 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110589407 | CMS |
| Alcon Vision LLC | $20.72 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110589403 | CMS |
| Alcon Vision LLC | $19.84 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110589401 | CMS |
| Alcon Vision LLC | $22.34 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110589405 | CMS |
| Alcon Vision LLC | $17.19 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110589399 | CMS |
| Amgen Inc. | $28.22 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115681898 | CMS |
| Bausch & Lomb Americas Inc. | $23.04 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140435738 | CMS |
| Bausch & Lomb Americas Inc. | $22.49 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140435736 | CMS |
| Johnson & Johnson Vision Care, Inc. | $13.30 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077738911 | CMS |
| Oyster Point Pharma, Inc. | $23.66 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147428307 | CMS |
| Tarsus Pharmaceuticals, Inc. | $29.57 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139100451 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.